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Conclusions: Many genes are relevant for the regeneration of joint damage
in the newt. Some are well known and can also be found in mammals.
Functional validations might help to move closer towards novel therapies
at least in part also driven by endogenously induced regeneration.
Cartilage/Chondrocyte Biology
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INTERLEUKIN 1 β (IL-1β) AND RESISTIN STIMULATE CHEMOKINE GENE
EXPRESSION BY ORDERED COMBINATORIAL BINDING OF TRANSCRIPTION
FACTORS C/EBPβ AND NF-κB
Z. Zhang1,2, J.L. Bryan1, E. DeLassus1, L.J. Sandell1
1Washington Univ. Sch. of Med., St.Louis, MO; 2First Aﬃliated Hosp. of Sun
Yat-sen Univ., Guangzhou, China
Purpose: IL-1β and the adipokine, resistin, are present in synovial joints
after injury. In vitro they stimulate a large set of chemokines which, as
mediators of cell recruitment, are known to be important in inﬂamma-
tory diseases, including rheumatoid arthritis (RA) and osteoarthritis (OA).
Toward the goal of regulating early events that lead to osteoarthritis, we
have investigated the mechanism by which chemokines are up regulated
in human articular chondrocytes.
Methods: Human articular chondrocytes were used to investigate the
response to IL-1β and the adipokine, resistin. The expression of
CCAAT/enhancer-binding protein β (C/EBPβ), and nuclear factor kappa
B (NF-κB) isoforms, p50, p65, rel-B, c-rel, were tested by quantitative
real-time polymerase chain reaction (qPCR) and western blotting. The
function of C/EBPβ and NF-κB on the chemokine genes, CCL3 and CCL4,
was examined by electrophoretic mobility shift assays (EMSA), chromatin
immunoprecipitation (ChIP), mutation, small interfering RNAs (siRNA),
pNF-κB reporter transfection, and NF-κB inhibitor (IKK-NBD) and C/EBPβ
inhibitor (SB303580) treatments. The co-regulation of C/EBPβ and NF-κB in
time was investigated by transfection, speciﬁc inhibition, and subcellular
localization with or without IL-1β and resistin stimulation.
Results: IL-1β and resistin are additive in their regulation of chemokine
genes. The expression of C/EBPβ and NF-κB isoforms, c-rel and p50, were
increased by IL-1β and resistin in human chondrocytes. The direct in-
volvement of C/EBPβ and NF-κB was demonstrated by DNA binding and
mutation of the binding domain in target genes, CCL3 and CCL4. C/EBPβ
regulated basal activity and the binding steadily increased over time up
to 24 hrs with IL-1β or resistin. In contrast, NF-κB did not regulate basal
activity of CCL3 and CCL4, but was up-regulated upon induction with IL-1β
or resistin, peaking at 8 hrs. C/EBPβ and NF-κB co-enhance the CCL3 and
CCL4 expression and inhibition of C/EBPβ or NF-kB activity was additive.
Figure 1. Subcellular localization of C/EBPβ and NF-κB isoform c-Rel in reponse to IL-1β (1
ng/ml) and resistin (100 ng/ml).
Figure 2. The potential transcriptional model for the up-regulation of chemokine genes in
human chondrocytes.
The timing of transcription factor activation in chondrocytes was conﬁrmed
by subcellular localization of C/EBPβ and c-rel by immunoﬂuorescence
microscopy (Fig. 1). A model of this regulation is shown in Fig. 2.
Conclusion: IL-1β and resistin both play a role in induction of chemokine
synthesis. The transcription factors, C/EBPβ and NF-κB are both involved
in the up-regulation of chemokine genes in human chondrocytes in a
time-ordered manner: NF-κB provides an initial up regulation and C/EBPβ
sustains increased gene expression. Thus, regulation of inﬂammation in
OA will need to account for resistin as well as IL-1β and the function
of C/EBPβ as well as NF-κB in gene regulation. Our results suggest that
chemokine genes in tissues such as cartilage, may be regulated differently
than in inﬂammatory cascades in circulating cells with more emphasis
on control by transcription factors other than NF-κB, particularly C/EBPβ.
Lastly, a newest report indicates that mice lacking C/EBPβ are protected
from OA. Our results shed light on the mechanism of action of this pivotal
transcription factor.
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INHIBITION OF HYPOXIA-INDUCIBLE FACTOR TARGETTING PROYL
HYDROXYLASE DOMAIN-CONTAINING PROTEIN 2 (PHD2) ENHANCES
MATRIX SYNTHESIS BY HUMAN CHONDROCYTES
B.L. Thoms, C.L. Murphy
Kennedy Inst. of Rheumatology. Imperial Coll. London, London, United
Kingdom
Purpose: Human articular cartilage is an avascular tissue, and therefore
functions in a hypoxic environment. Chondrocytes have adapted to this and
actually use hypoxia to drive tissue-speciﬁc functions. We have previously
shown that hypoxia enhances cartilage matrix synthesis in human chon-
drocytes, speciﬁcally through Hypoxia Inducible Factor 2-alpha (HIF-2α)
mediated upregulation of master regulator transcription factor SOX9, which
in turn drives expression of the main cartilage-speciﬁc extracellular matrix
genes. Under normoxic conditions the HIF-α subunit is hydroxylated on
speciﬁc conserved proline residues by proyl-hydroxylase domain enzymes
(PHDs). This hydroxylation signals the α-subunit’s polyubiquitination and
subsequent degradation. PHDs are the direct oxygen sensors of the cell
requiring molecular oxygen as a co-substrate. Here we have investigated
the regulation of HIF-α isoforms by hydroxylases using siRNA against
PHD1/PHD2/PHD3 with the aim of stabilising HIF-2α, up-regulating SOX9
and increasing cartilage matrix deposition.
Methods: Healthy human articular chondrocytes (HACs) were cultured as
a monolayer at 20% or 1% oxygen. Hydroxylases were broadly inhibited
using either dimethyloxalylglycine (DMOG) or speciﬁcally inhibited using
siRNA. The resulting HIF-α stabilization was assessed using western blot
and the expression of chondrocyte markers (SOX9) and key cartilage
extracellular matrix proteins (COL2A1, COL9A1, COL11A2 and AGGRECAN)
using real-time PCR and western blot.
Results: We report the successful knockdown of PHD1/2/3 in freshly
isolated and passaged chondrocytes. PHD2 was identiﬁed as the dominant
isoenzyme in HACs regulating HIF-2α stability in human chondrocytes.
Moreover, speciﬁc inhibition of PHD2 using RNAi-mediated depletion
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caused an upregulation of SOX9 and enhanced extracellular matrix protein
production.
Conclusions: Depletion of PHD2 resulted in greater HIF-2α levels, and
therefore enhanced SOX9-induced cartilage matrix production compared
to the levels normally found in hypoxia (1% oxygen) implying that PHD2
inhibition offers a novel means to promote the chondrocyte phenotype and
enhance cartilage repair in vivo.
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CARTILAGE-SPECIFIC KNOCKOUT OF SITE-1 PROTEASE IN POSTNATAL
MICE RESULTS IN AN ABNORMAL GROWTH PLATE WITH DISRUPTION OF
HYPERTROPHIC CHONDROCYTE DIFFERENTIATION AND SUBSEQUENT
CHONDRODYSPLASIA
D. Patra, E. DeLassus, S. Hayashi, L.J. Sandell
Washington Univ. Sch. of Med., St. Louis, MO
Purpose: Site-1 protease (S1P) is a proprotein convertase that plays an
essential role in the processing of latent, membrane-bound transcription
factors such as SREBPs and ATF6, to their active form. Cartilage-speciﬁc
knockout of S1P in mice (S1Pcko) results in chondrodysplasia with complete
lack of endochondral bone formation. These mice exhibited poor cartilage
development with a drastic decrease of collagen type IIB (Col IIB) in the
matrix. Most of the Col IIB appears trapped inside the cell. Ultrastructural
analysis of the cartilage showed engorged and fragmented endoplasmic
reticulum. S1Pcko mice die during or very soon after birth and therefore the
study was restricted to embryonic time-points. The goal of this study is to
investigate the role of S1P in cartilage/endochondral bone development at
various developmental stages in postnatal mice with the intent to identify
and dissect S1P-regulated pathways fundamental to skeletal development.
Methods: S1Pf/f mice (homozygous for the S1Pﬂox allele with ﬂoxed S1P
exon 2) were crossed with Col2-CreER(T) mice (positive for Col2-CreER(T)
transgene where Cre recombinase-mutant estrogen receptor [ER(T)] fusion
protein is active only in presence of tamoxifen) and the progeny back-
crossed with S1Pf/f to create S1Pf/f;Col2-CreER(T) mice. Cartilage-speciﬁc
deletion of S1P in postnatal mice (S1Pcko-ER(T)) was achieved by injecting
S1Pf/f;Col2-CreER(T) mice with tamoxifen at P1 (1 day old) or P7 (7 day
old) timepoints and harvested a week or more later. Tamoxifen injections
were done for some pregnant mice at E18.5. The cartilage/bone from
S1Pcko-ER(T) mice and its wild type (WT) littermates were studied by X-
ray microtomograph (Micro-CT), histology, immunohistochemistry (IHC),
immunoﬂuorescence (IF), and in situ hybridization.
Results: S1Pcko-ER(T) mice exhibit chondrodysplasia with severity depending
on the timing of tamoxifen injection after birth. The younger the injected
animals, the more pronounced the difference from its WT littermates, with
tamoxifen injection of the mother at E18.5 being the most drastic. Micro-
CT analysis of femurs and humeri showed that the bones in S1Pcko-ER(T)
mice were smaller with abnormal trabecular development. S1Pcko-ER(T) mice
appeared osteoporotic with drastically reduced trabecular bone (Fig. 1).
Trabecular bone developed in an arbitrary fashion with individual trabecu-
lae being thicker, with higher bone mineral density and with more spacing
between them, than in WT. Histological analysis showed that chondrocyte
hypertrophic differentiation was disrupted in S1Pcko-ER(T) mice and further
conﬁrmed by a loss of type X collagen expressing cells in the growth plate.
S1Pcko-ER(T) mice injected at P1 did not develop a secondary ossiﬁcation
center; IHC and IF analysis of these mice demonstrated that Col IIB was
trapped primarily inside cells which would otherwise differentiate to be
hypertrophic in the secondary ossiﬁcation center in WT.
Figure 1. Micro-CT analysis of femurs from WT and S1Pcko-ER(T) mice showing the osteo-
porotic nature of the femur in the mutant mice.
Conclusions: S1P is essential to endochondral bone development in post-
natal mice. Bone lengthening is drastically reduced in S1Pcko-ER(T) mice. The
absence of type X collagen expressing cells in S1Pcko-ER(T) mice suggests
a defective growth plate diminishing bone elongation and implicates S1P
in regulating hypertrophic differentiation in postnatal mice. As this is
not seen in the S1Pcko mice, S1P may have additional roles in postnatal
mice toward skeletal development. The entrapment of Col IIB in the
hypertrophic differentiation-arrested cells underscores a role for S1P in
cartilage matrix homeostasis. The osteoporotic nature of the bone alludes
to the importance of S1P in maintaining endochondral bone homeostasis.
The phenotype in S1Pcko-ER(T) mice is similar to that seen in humans with
congenital achondroplasia and this attests to the fundamental requirement
of S1P in mammalian skeletal development. Understanding this fundamen-
tal requirement should be useful in treating cartilage diseases and tissue
engineering.
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POST-TRANSCRIPTIONAL REGULATION OF CYCLOOXYGENASE-2
EXPRESSION BY MICRORNA-199a* IN HUMAN OA CHONDROCYTES
N. Akhtar, Z. Rasheed, T.M. Haqqi
MetroHlth. Med. Ctr./CWRU, Cleveland, OH
Purpose: MicroRNAs (miRNAs) are small non-coding RNAs that modify
the properties of the cells by altering the translational proﬁle of mRNAs
to produce a proteome with unique functional properties. Interleukin-1β
(IL-1β) mediated over expression of cyclooxygenase-2 (COX-2) contributes
to the inﬂammation and joint degeneration in osteoarthritis (OA) patients.
In this study we determined the posttranscriptional regulation of COX-2 by
miRNAs in human OA and normal chondrocytes stimulated with IL-1β.
Methods: Chondrocytes were derived by enzymatic digestion following
our standard protocol using cartilage from normal (trauma cases with
no history of OA) and OA patients undergoing total joint arthroplasty.
Isolated chondrocytes were stimulated with IL-1β (5 ng/ml) in vitro. Total
RNA was prepared using the TRIZOL reagent and miRNAs were puriﬁed
using the mirVANA system. Single stranded cDNA was synthesized using
stem loop-speciﬁc primers and the expression of miRNAs of interest was
quantiﬁed using TaqMan miRNA expression assay and their target mRNA
was identiﬁed using bioinformatics. Transfection of chondrocytes with a
3’UTR reporter construct and pre-miRNAs was employed to verify the
miRNA:mRNA interaction. Expression of COX-2 mRNA was determined by
qRT-PCR using validated primers. Expression of COX-2 protein in OA chon-
drocytes transfected with pre-miRNAs and anti-miRNAs was determined by
Western immunoblotting. Role of p38-MAPKs and NF-κB in the regulation
of miRNAs and COX-2 expression in chondrocytes was evaluated using
speciﬁc inhibitors. Data was analyzed using Origin 6.1 software package
and p<0.05 was considered signiﬁcant.
Results: We recently performed the miRNAs expression proﬁle in human
OA chondrocytes stimulated with IL-1β and discovered that the expression
of several miRNAs, including miR-101_3, and miR-199a*, was suppressed
signiﬁcantly (>2 fold, p<0.05). Kinetic analysis showed a differential pat-
tern of expression of miR-101_3, and miR-199a* miRNAs at 6 and 24
h post-stimulation with IL-1β. In human OA chondrocytes, expression
of miR-101_3 was down regulated at 6 h (2.1-fold ± 1.0; n=7) but no
signiﬁcant change was observed at 24 h (n=11). In contrast, normal human
chondrocytes showed down regulation of miR-101_3 (1.7-fold ± 0.53; n=3)
at 24 h with no change at 6 h post-stimulation with IL-1β. Expression of
miR-199a* was signiﬁcantly down regulated in OA chondrocytes stimulated
with IL-1β at 24 h (3.3-fold ± 1.5; n=11, p<0.05) but not at 6 h (0.94-fold
± 0.86; n=7, p>0.05). Importantly, in human OA chondrocytes stimulated
with IL-1β expression of COX-2 protein was also found to be high at 24 h,
compared to 6 h post stimulation and this inversely correlated with the
expression of miR-199a*. Normal human chondrocytes also showed similar
inverse correlation of COX-2 protein and miR-199a* expression at 6 h
(1.1-fold ±0.023; n=3, p>0.05) and 24 h (2.2-fold ± 0.65; n=3, p<0.05) after
stimulation with IL-1β. In silico analysis identiﬁed the sequences conserved
in the 3’UTR of human COX-2 mRNA (NM_000963) complimentary to the
seed sequence of miR-101_3, and miR-199a*. Over expression of miR-199a*
in human OA chondrocytes inhibited the IL-1β-induced expression of COX-
2 protein. On the other hand transfection with an inhibitor of miR-199a*
enhanced the IL-1β-induced expression of COX-2 protein in human OA
chondrocytes. Co-transfection of human OA chondrocytes with a luciferase
reporter construct containing the 3’-UTR of human COX-2 mRNA and the
miR-199a* mimic suppressed the luciferase enzyme activity signiﬁcantly
(p<0.001). No inhibition of luciferase enzyme activity was observed in
OA chondrocytes transfected with either miR-199a* inhibitor or scrambled
